Total Payments
$249,067
2024 Payments
$18,774
Companies
7
Transactions
198
Medicare Patients
14,228
Medicare Billing
$829,200
Payment Breakdown by Category
Other$164,010 (65.8%)
Consulting$44,349 (17.8%)
Travel$30,109 (12.1%)
Research$7,424 (3.0%)
Food & Beverage$3,114 (1.3%)
Education$61.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100,505 | 27 | 40.4% |
| Honoraria | $63,505 | 23 | 25.5% |
| Consulting Fee | $44,349 | 9 | 17.8% |
| Travel and Lodging | $30,109 | 92 | 12.1% |
| Unspecified | $7,424 | 1 | 3.0% |
| Food and Beverage | $3,114 | 44 | 1.3% |
| Education | $61.27 | 2 | 0.0% |
Payments by Type
General
$241,643
197 transactions
Research
$7,424
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stemline Therapeutics Inc. | $144,345 | 102 | $0 (2023) |
| Seattle Genetics, Inc. | $36,131 | 33 | $0 (2019) |
| Blueprint Medicines Corporation | $32,668 | 25 | $0 (2024) |
| Innate Pharma, Inc | $14,848 | 2 | $0 (2020) |
| Kyowa Kirin, Inc. | $11,931 | 18 | $0 (2024) |
| Seagen Inc. | $5,319 | 7 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $3,825 | 11 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,774 | 20 | Blueprint Medicines Corporation ($14,928) |
| 2023 | $25,664 | 21 | Blueprint Medicines Corporation ($17,741) |
| 2022 | $35,425 | 20 | Stemline Therapeutics Inc. ($35,305) |
| 2021 | $40,220 | 26 | Stemline Therapeutics Inc. ($40,156) |
| 2020 | $63,438 | 37 | Stemline Therapeutics Inc. ($43,271) |
| 2019 | $25,711 | 31 | Stemline Therapeutics Inc. ($25,590) |
| 2018 | $10,577 | 7 | Seattle Genetics, Inc. ($10,577) |
| 2017 | $29,258 | 36 | Seattle Genetics, Inc. ($25,432) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: Monoclonal Antibody | ||||||
| 09/17/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: Monoclonal Antibody | ||||||
| 09/17/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $101.23 | General |
| Category: Monoclonal Antibody | ||||||
| 09/11/2024 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $1,242.00 | General |
| 09/03/2024 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $4,347.00 | General |
| 09/03/2024 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $1,242.00 | General |
| 09/03/2024 | Blueprint Medicines Corporation | — | Travel and Lodging | Cash or cash equivalent | $179.29 | General |
| 08/06/2024 | Blueprint Medicines Corporation | — | Travel and Lodging | In-kind items and services | $133.48 | General |
| 08/06/2024 | Blueprint Medicines Corporation | — | Travel and Lodging | In-kind items and services | $113.47 | General |
| 08/06/2024 | Blueprint Medicines Corporation | — | Travel and Lodging | In-kind items and services | $80.00 | General |
| 08/05/2024 | Blueprint Medicines Corporation | — | Travel and Lodging | In-kind items and services | $251.52 | General |
| 07/31/2024 | Blueprint Medicines Corporation | — | Food and Beverage | In-kind items and services | $20.76 | General |
| 06/08/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $101.44 | General |
| Category: Monoclonal Antibody | ||||||
| 03/09/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $146.58 | General |
| Category: Monoclonal Antibody | ||||||
| 03/08/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $93.71 | General |
| Category: Monoclonal Antibody | ||||||
| 02/22/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $36.10 | General |
| Category: Monoclonal Antibody | ||||||
| 02/14/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Monoclonal Antibody | ||||||
| 01/31/2024 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $6,521.00 | General |
| 01/19/2024 | Blueprint Medicines Corporation | — | Travel and Lodging | In-kind items and services | $717.20 | General |
| 01/19/2024 | Blueprint Medicines Corporation | — | Travel and Lodging | In-kind items and services | $80.00 | General |
| 12/20/2023 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $1,242.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/12/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $840.00 | General |
| Category: Monoclonal Antibody | ||||||
| 11/20/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: Monoclonal Antibody | ||||||
| 11/03/2023 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Travel and Lodging | In-kind items and services | $300.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/03/2023 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Travel and Lodging | In-kind items and services | $26.00 | General |
| Category: Oncology / Rare Diseases | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| An Open Label, Multicohort, Multi-center Phase II Study Evaluating the Efficacy and Safety of IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T-cell Lymphoma | Innate Pharma, Inc | $7,424 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 3,281 | 5,287 | $1.5M | $236,786 |
| 2022 | 20 | 3,293 | 6,242 | $829,812 | $171,685 |
| 2021 | 20 | 3,891 | 7,239 | $1.1M | $220,506 |
| 2020 | 20 | 3,763 | 6,991 | $963,126 | $200,222 |
Total Patients
14,228
Total Services
25,759
Medicare Billing
$829,200
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,537 | 2,159 | $1.0M | $139,618 | 13.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 558 | 892 | $158,776 | $22,704 | 14.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 150 | 166 | $73,040 | $17,556 | 24.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 115 | 459 | $34,425 | $10,012 | 29.1% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 117 | 398 | $47,760 | $9,833 | 20.6% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Office | 2023 | 46 | 200 | $26,000 | $5,050 | 19.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 119 | 127 | $36,830 | $4,960 | 13.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 145 | 186 | $17,298 | $4,784 | 27.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 133 | 147 | $29,400 | $4,461 | 15.2% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 33 | 66 | $9,108 | $2,138 | 23.5% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 30 | 32 | $8,896 | $2,080 | 23.4% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Office | 2023 | 45 | 48 | $11,480 | $2,060 | 17.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 51 | 84 | $5,628 | $1,691 | 30.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 15 | 26 | $8,762 | $1,679 | 19.2% |
| 88323 | Surgical pathology consultation and report on referred material requiring preparation of slides | Facility | 2023 | 25 | 26 | $5,902 | $1,643 | 27.8% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2023 | 20 | 20 | $7,360 | $1,321 | 17.9% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2023 | 25 | 35 | $5,040 | $1,169 | 23.2% |
| 85097 | Bone marrow, smear interpretation | Facility | 2023 | 26 | 27 | $6,237 | $1,027 | 16.5% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2023 | 11 | 44 | $3,344 | $999.79 | 29.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 37 | 89 | $5,785 | $824.75 | 14.3% |
| 88364 | Genetic sequencing localization, each additional procedure | Facility | 2023 | 17 | 28 | $2,548 | $750.13 | 29.4% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2023 | 11 | 11 | $1,111 | $292.58 | 26.3% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 15 | 17 | $1,598 | $133.50 | 8.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 1,370 | 2,354 | $419,012 | $66,814 | 15.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 350 | 1,465 | $109,875 | $32,800 | 29.9% |
About Dr. Alejandro Gru, MD
Dr. Alejandro Gru, MD is a Dermatopathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689899817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alejandro Gru, MD has received a total of $249,067 in payments from pharmaceutical and medical device companies, with $18,774 received in 2024. These payments were reported across 198 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($100,505).
As a Medicare-enrolled provider, Gru has provided services to 14,228 Medicare beneficiaries, totaling 25,759 services with total Medicare billing of $829,200. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Anatomic Pathology
- Location New York, NY
- Active Since 04/14/2007
- Last Updated 05/30/2023
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1689899817
Products in Payments
- ELZONRIS (Drug) $92,095
- ADCETRIS (Biological) $27,266
- Poteligeo (Drug) $11,747
- SGN35 (Biological) $9,005
- AYVAKIT (Drug) $7,745
- Lumoxiti (Drug) $7,424
- OPDIVO (Biological) $3,825
- POTELIGEO (Drug) $183.54
- SGN-CD33A (Biological) $70.09
- Orserdu (Drug) $22.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in New York
Dr. Mitchell Mandel, M.d, M.D
Dermatopathology — Payments: $12,844
Dermatopathology $12,844
Tatyana Groysman, D.o, D.O
Dermatopathology — Payments: $7,965
Dermatopathology $7,965
Dr. Travis Hollmann, M.d., Ph.d, M.D., PH.D
Dermatopathology — Payments: $4,436
Dermatopathology $4,436
Robert Phelps, Md, MD
Dermatopathology — Payments: $3,397
Dermatopathology $3,397
Seth Wilentz, Md, MD
Dermatopathology — Payments: $923.07
Dermatopathology $923.07
Elen Blochin, Md, MD
Dermatopathology — Payments: $703.73
Dermatopathology $703.73